Loading
Alibaba Health Information Technology Ltd. Stock: price and insider trades · Hong Kong
1 insider bought €19k of shares over the last 90 days, the latest by Sheng Mengyue, filed 20 Aug 2026.
Insider Decl.
116
Thresholds
n/a
Buy Volume
€2M
30 ops. · all time
Sell Volume
€18M
31 ops. · all time
Who traded when
BuySaleShen Difan2 buys2 sales
Tu Yanwu1 buy2 sales
Sheng Mengyue1 buy
Zhu Shunyan1 sale
Since the insiders bought
- -7.7%Entry HK$5.85 · Close at T+30 HK$5.40
- -13.2%Entry HK$104.97 · Close at T+90 HK$91.14
- +22.4%Entry HK$7.68 · Close at T+365 HK$9.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Alibaba Health Information Technology Ltd. Buy (bullish), based on 15 analysts. Average price target: HK$4.43.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,917 of 26,289 companies
53.9
score / 100
Value44
Quality64
FCF yld2.6%
Earn yld4.1%
EV/EBITDA20.5x
ROE11%
Gross mgn24%
Net mgn5.7%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
HK$2.95
Analyst consensus
15 analystsBuy
HK$2.61Target HK$4.43(+51%)HK$8.03
Income statement
RevenueHK$34.3B
Gross profitHK$8.2B24% margin
EBITDAHK$2.3B7% margin
Net incomeHK$1.9B5.7% margin
Valuation
PER (trailing)22.7x
PER (forward)18.7x
P/Book2.3x
Beta1.58
Balance sheet & cash
Market capHK$47.6B
Total debtHK$59.8M
Free Cash FlowHK$1.2B
Debt / Equity0%
Profitability & ownership
ROE11.3%
ROA5.2%
% insiders63.5%
% institutions14.3%
Last declaration on 20 August 2026
Declarations116 total
52,000 shares@ HK$3.260.0004% mcap100.0% of flowShareXHKGHKEX:DA20260820E00206
Canonical exit: 15 Nov 2026 (T+90)
517,525 sharesShareXHKGHKEX:DA20260617E00415
3,196,900 sharesShareXHKGHKEX:DA20260617E00416
Canonical exit: 13 Sept 2026 (T+90)
75 shares@ HK$5.24030.0% of flowShareXHKGHKEX:DA20251219E00430
75 shares@ HK$5.24030.0% of flowShareXHKGHKEX:DA20251219E00433
85,050 sharesShareXHKGHKEX:DA20251216E00306
56,700 sharesShareXHKGHKEX:DA20251216E00305
140,043 shares@ HK$4.57259.0% of flowShareXHKGHKEX:DA20250623E00222
62,714 shares@ HK$4.5725100.0% of flowShareXHKGHKEX:DA20250623E00216
83,317 shares@ HK$4.57253.7% of flowShareXHKGHKEX:DA20250623E00212
466,150 sharesShareXHKGHKEX:DA20250618E00435
234,775 sharesShareXHKGHKEX:DA20250618E00436
322,275 sharesShareXHKGHKEX:DA20250618E00417
2,381,400 sharesShareXHKGHKEX:DA20250617E00320
Canonical exit: 11 Sept 2025 (T+90)
453,600 sharesShareXHKGHKEX:DA20250617E00306
Canonical exit: 11 Sept 2025 (T+90)
164,883 shares@ HK$3.38915.8% of flowShareXHKGHKEX:DA20240621E00376
2,438,100 sharesShareXHKGHKEX:DA20240619E00403
Canonical exit: 12 Sept 2024 (T+90)
270,225 sharesShareXHKGHKEX:DA20240619E00368
75,125 sharesShareXHKGHKEX:DA20240619E00390
331,176 sharesShareXHKGHKEX:DA20240619E00404
2,742,900 sharesShareXHKGHKEX:DA20240619E00367
Canonical exit: 12 Sept 2024 (T+90)
696,600 sharesShareXHKGHKEX:DA20240619E00389
Canonical exit: 12 Sept 2024 (T+90)
192,500 sharesShareXHKGHKEX:DA20230920E00079
358,050 sharesShareXHKGHKEX:DA20230620E00440
Canonical exit: 13 Sept 2023 (T+90)
239,092 sharesShareXHKGHKEX:DA20230620E00373
25 of 116 declarations
About Alibaba Health Information Technology Ltd.
Among the directors of Alibaba Health Information Technology Ltd., a healthcare company listed on the Hong Kong stock exchange and valued at HKD 47.6 billion, the largest trade is a sale: EUR 8,803,172 filed on February 10, 2020 by Wang Lei (Director), followed by EUR 2,407,763 on July 3, 2020. Wang Qiang (Director) sold EUR 1,572,020 on June 9, 2020. In all, 31 sales, every one with an amount, come to EUR 18,010,578, median EUR 71,073.
Of the 30 purchases, only 10 carry an amount: EUR 1,710,770, median EUR 123,336. The three largest come from Shen Difan (EUR 517,491 on November 26, 2021) and Zhu Shunyan (EUR 372,389 on August 2, 2021 and EUR 276,299 on August 4, 2021). Purchases make up 49% of open-market trades. Tu Yanwu is the first filer with 27 filings (7 purchases, 8 sales), ahead of Shen Difan (25, of which 10 purchases).
Read moreShow less
The record holds 116 filings published between October 13, 2017 and August 20, 2026, from 8 filers, 55 of them of another kind. Annual volume reaches 35 filings in 2020, against 7 in 2024. Median publication delay: 4 days. For 10 purchases the 90-day median result is minus 22.7%, with no positive result (recorded past results, not a forecast). Insiders hold 63.5% of the capital.
